Close Menu

NEW YORK (GenomeWeb) – A new study by Veracyte and collaborators demonstrates that the company’s Envisia genomic test can improve the diagnosis of patients being evaluated for interstitial lung disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.